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The action of guinea pig serum in bringing  about in vivo, the regression  of 3 
transplanted mouse and rat lymphomas was first described by Kidd in papers 
from this laboratory in 1953 (1, 2). Several highly specific features were shown: 
first,  that inhibition was produced only by guinea pig serum, sera from other 
animal species being completely devoid of effect. Secondly, susceptibility to the 
effects of guinea pig serum was found to be sharply confined  to certain tumor 
cell lines.  Thus, although 3 lymphomas were found initially to be sensitive to 
guinea pig serum,  14 other tumor cell lines  of similar morphology were not 
inhibited in subsequent tests. Since this time, however, a number of additional 
cell  lines  of widely differing  histological  types, notably the Walker  carcino- 
sarcoma,  the  rat  fibrosarcoma  ACMCA2,  and  recently  10  different  newly 
induced mouse lymphomas, have been shown to be guinea pig serum-sensitive 
(3-5).  Thirdly,  although  guinea  pig  serum  proved  highly  effective in  ~ivo 
against  tumor cells of sensitive lines,  particularly lymphomas 6C3HED and 
A2, it produced no sign of toxicity in the hosts and furthermore proved innoc- 
uous for Lymphoma 6C3HED cells when held in  contact with  them in vitro 
during several hours at 37°C. 
The experiments pedormed at this time, however, did not make it possible 
to determine which of the constituents of guinea pig serum were responsible 
for the antllymphoma  effects.  In this paper the question has been examined 
further, using ceils of Lymphonm 6C3HED, and in a companion paper observa- 
tions are reported which throw light  on a  particular  character  of these neo- 
plastic cells that may determine their susceptibility to the effects of guinea pig 
serum in vivo. 
* Support for these investigations was generously provided by- Mr. John W. O'Boyle, the 
American Cancer Society, and The National Cancer Institute. 
Partly described in Nature, 1961, 191,  1114. 
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Since guinea pig serum has long been known to be a particularly rich source 
of the different fractions of complement, it was initially considered that these 
or  similarly acting  substances might be  responsible for  inhibition of  tumor 
growth.  A  number of  immunological experiments made by the  author  were 
deemed incompatible with  such  an  explanation, however,  and  a  search  was 
made for an entirely different possibility. One such possibility was suggested by 
an observation made more than 40 years ago by Clementi, namely that the 
serum of guinea pigs, but not of other mammals, is a rich source of the enzyme 
L-asparaginase (6). The activities and properties of this enzyme in guinea pig 
serum were therefore compared with those of the substance responsible for the 
antilymphoma effects, with the results now to be described. 
Methods 
The hypothesis that L-asparaginase might be the antilymphoma  substance in guinea pig 
serum was tested  by obtaining preparations  and fractions  of the serum and determining 
whether  their antilymphoma  effect could be predicted  by measurements of L-asparaginase 
activity. Thus, using whole guinea pig serum the effects of heat and alterations in pH on these 
activities were examined. Similar comparisons were made in specimens of serum obtained 
from newborn guinea pigs and in protein fractions of normal serum obtained by means of 
salt precipitation, starch block electrophoresis, and chromatography on DEAE cellulose. 
Mice.--ZBC mice (C3H backcross), obtained from the late Dr. J. J. Bittner of the Univer- 
sity of Minnesota, Minneapolis, were used in all the present experiments. They were main- 
tained on Purina chow and water ad lib. 
Tumor Cdls.--Cells of the mouse lymphoma 6C3HED were used in all experiments to be 
described. A cell line of the lymphoma has been maintained  by serial subcutaneous transfer in 
C3H or ZBC mice in this laboratory since 1945. 
Implantation  and Measurement of Tumor Growth.--The  techniques used were modified 
from those described by Kidd (I). Solid subcutaneous tumors were removed under sterile 
conditions and gently squeezed through  a stainless steel mesh into 10 to  15 ml of  cooled 
Ringer's solution or buffered glucose-Ringer's solution. The lymphoma suspension was then 
transferred to a 25 ml measuring cylinder which was placed in the refrigerator at 4°C. The 
larger particles were allowed to settle, leaving a suspension of single cells, which was suitably 
diluted to contain 100,000 living ceils per ml, when counted  by the method of Schreck (7). 
Portions  of the tumor cell suspension were examined on each occasion for bacteriological 
contamination by inoculation of nutrient broth and nutrient agar slopes. They proved con- 
sistently to be sterile. 
The procedure in experiments to assay antilymphoma activity of guinea pig serum prepa- 
rations was as follows: ZBC mice, weighing 23 to 26 gin, separated from the main stock and 
placed in groups of three at least 1 week previously, were implanted on each side with 50,000 
Lymphonm 6C3HED ceils. Cell suspensions  were injected through shaved areas in the groins 
to form subcutaneous blebs inferolaterally, just beneath the costal margins. In each experi- 
ment up to 70 groups were used. 1 to 2 hours after tumor cell implantation, mice in a number 
of these groups were injected intraperitoneally  with guinea pig serum in quantities of 2.0, 1.0, 
0.5, and 0.25 ml, at least 2 groups receiving each amount. Substances under test for anti- 
lymphoma activity were injected into further groups of animals, each substance being injected 
into all the animals of at least 1 group. A number of groups interspersed amongst the rest 
were used as untreated controls. 
In every experiment control animals were examined daily from the 7th day after implanta- j.  D. BRoom~  i01 
tion. When tumors first became palpable in these, daily examination of all the experimental 
animals was begun and  the presence and size of  the tumors  as judged  by palpation  was 
recorded. 
After using the implantation technique described, tumors first appeared as papular lesions 
0.2 to 0.3 cm in diameter in the skin of the implantation site, where they were readily detected 
both visually and by palpation. In untreated animals, tumors appeared in different experi- 
ments after an average of 9 to 12 days, but within any one experiment there was considerable 
consistency. Table I  illustrates this with the results from a number of groups  of untreated 
TABLE I 
The Times of First Appearance of Tumors in ZBC Mice Imflanfed u~I~ Cdls  of 
Lymphoma  6C3HED* 
Mice from  Experiment  group Nb. 
1  1 
6 
11 
54 
59 
2  1 
6 
9 
34 
59 
50 
3  1 
8 
19 
Outcome of implantation 
Number of tumors in each group of mice with the following latent periods 
dal 
w 
w 
days 
5 
6 
5 
6 
5 
5 
4 
4 
6 
1 
5 
da: 
$ 
1 
1 
1 
2 
2 
4 
1 
2 
11 days 
1 
12 days 
M 
2 
2 
Average 
9 days 
9 days 
11 days 
* Each test group consisted of 3 ZBC mice implanted  with 50,000 6C3HED  cells in each 
side, as described in the text, and afterwards untreated. 
controls which were part of experiments to be described later. In the control groups of each 
experiment, tumors appeared in a  similar manner,  the majority on the same day and only 
rarely with an interval of more than 1 day from this.  From such a base line in the controls, 
the inhibitory activity of small quantities of guinea pig serum or derivatives of it, could be 
measured from the delay in the appearance of tumors in treated animals. 
Delay occurred in  a stepwise fashion, being just detectable (an average of 3 days) in ani- 
mals given 0.25 ml of guinea pig serum; it was greater in animals given 0.5 ml (an average of 
6 days) and increased to complete tumor suppression when 1.0 to 2.0 ml of guinea pig serum 
was given. Mice implanted with lymphoma ceils in the way described were considered "cured" 
if no tumor appeared and they remained healthy during an observation period of 50 days. In 
practice 30 days was the longest observed latent period of any tumor. 
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TABLE  II 
Relationship of the Dosage of Guinea Pig Serum Used in Treatmera to the Degree of 
Inhibition of Cells of Lymphoma 6C3ttED 
Experiment* 
1  9 
2  9 
3  li 
Total 
72 
72 
70 
71 
Outcome of implantatlon~ 
Controls: day of 
tumor appearance 
Days of tumor inhibition in groups of mice treated with the 
following quantities of guinea pig serum§, 
2.0 ml 
Average 
72 
70 
71 
1.0 ml  0.5 ml 
Total 
16 
19 
15 
16 
18 
11 
15 
12 
14 
12 
Total  Average 
72  72 
72 
72 
72 
72 
70  67 
63 
71  68 
64 
Total  Average 
36  39 
32 
47 
34 
46 
39  36 
32 
44  48 
51 
o.2S~l 
Averag¢ 
16 
14 
13 
* Other parts of the experiments designated are shown in Table I. 
Groups of 3 ZBC mice were implanted with 50,000 lymphoma cells in each side. Details 
of the methods of lymphoma cell implantation and of treatment with guinea pig serum are 
described in the text. 
§ To explain the manner of calculating the number of days of tumor inhibition the example 
of Experiment 2 will be quoted. In this and all other cases,  calculations were based on groups 
of 3 mice, each implanted with 2 tumors. It was seen in Table I  that most tumors in Experi- 
ment 2 were first observed on the 9th day after implantation. If all had been observed on this 
day, then in the test period, which here would be the 9th day and the 11 successive days 
there would have been 12  X  6  =  72 "tumor days." In fact  there was a  scatter in the time 
of appearance of tumors in control animals, so that there was an average number of 70 tumor 
days in each group. Complete suppression of tumor growth in a group of animals treated with 
2 mi of guinea pig serum, as shown in the table, therefore caused 70 days of tumor inhibition. 
I] L-Asparaginase assays of the guinea pig serum samples used in treatment: Experiment 1, 
69.2 units/ml; Experiment 2, 87.1 units/ml; Experiment 3, 69.3 units/ml. 
but it has been found useful in practice to measure in each group of 3 treated animals the total 
number of days in which tumor appearance was delayed beyond the average of that found in 
control groups2 A limit was made at the 11th day after the appearance of tumors in untreated 
controls; from this time there was little change in the pattern of the "chartings,"  and, of 
tumors suppressed to this time, less than 10 per cent appeared subsequently. In Table II it will 
1 For instance, if in all the animals of control groups, tumors appeared on the 10th day, and 
in a  group of treated animals 3 tumors appealed on the 14th and 3 on the 16th days, there 
would be 3 X  4 -b 3 X  6  -~ 30 "days of tumor inhibition." j.  D.  BROOKE  103 
be seen that measurements of the number of "days of tumor inhibition" made in the way 
described show a progressive rise in groups of animals treated with increasing quantities of 
guinea pig serum, providing a suitable set of standards in each experiment to assay antilym- 
phoma activity. 
After their first appearance tumors grew progressively  to bring about the death of the host 
animal 24 to 32 days after implantation. The subcutaneous tumors were by this time ulcerated 
and hemorrhagic and there was extensive visceral metastasis. 
C~inea .Pig Serum was obtained from market-bought adult animals of random breed and 
either sex. 15 to 20 ml of blood was obtained from each under aseptic conditions by cardiac 
puncture, without anesthesia. Most animals were bled on several occasions  but at intervals 
of at least 6 weeks between bleedings. Serum from groups of 15 to 30 animals was pooled, and 
kept at --20°C until required. Samples from each batch of pooled serum were inoculated into 
nutrient broth and nutrient agar; they consistently showed  no evidence of bacterial eon- 
tamlnation. 
Newborn a~imsls (within 48 hours of birth) were rendered unconscious  by placing them 
above a quantity of solid COs. Under aseptic conditions the thorax was then opened and  the 
animals exsangninated by cardiac puncture. Approximately  2 ml of blood was obtained from 
each animal. The serum from each animal was separated and kept frozen as already described. 
Assays of ~-Asparaginase Activity were performed by a  modification  of the method  de- 
scribed by Meister, Levintow, Greenfield, and Abendschein (8) measuring the rate of am- 
monia production from a standard r.-asparaginase solution. In this 0.2 ml samples of enzyme 
containing solutions were added to incubation mixtures at 37°C  consisting of 1 ml 0.1  ~t 
sodium boratebuffer pH 8.5, 1 ml 0.04 ~r L-asparagine, and 0.8 ml of 0.15 x¢ NaCI. Immedi- 
ately after adding the enzyme and 60 minutes later, I ml samples were withdrawn, and protein 
precipitated with tungstic acid solution. Ammonia in  the superuatant was estimated by 
nesslerization,  using with each batch of assays, standards containing 0.1 and 0.05 nag am- 
monia nitrogen/ml (as ammonium sulfate), and measuring ammonia concentrations in test 
solutions from a standard curve. 
The unit of L-asparaginase  activity employed was that which,  under the conditions de- 
scribed, liberated 1 micromole of ammonia from g-asparagine in 1 hour. 
.Protein Concentration was  measured  by the  Folin-Ciocalteu  method  as  modified  by 
Kunkel and Tiselius (9). 
~S~TS 
Inactivation  of r.-Asparaginase and  the Ant,Tymphoma  Substance  of Guinea 
Pig Serum at Different  Temperatures.--Earlier  experiments in  this laboratory 
(2) showed that the antilymphoma activity of guinea pig serum was relatively 
easily destroyed by heating; in guinea pig serum kept at 56°C slight inactiva- 
tion occurred, and at 66°C this became complete. Table III shows the result of 
an experiment in which a number of samples of guinea pig serum were incubated 
at varying temperatures for 30 minutes.  At 56°C  15.2  to  20.7  per cent  of L- 
asparaginase activity was  lost,  but  at  66°C  the  enzyme  was  almost entirely 
(82.9 to 87.8 per cent) destroyed. 
In the experiment shown in Fig.  1  a  comparison was made between the L- 
asparaginase and  antilymphoma activities of 3  samples of a  pooled batch of 
guinea pig serum which were heated at 46  °, 56  °, and 66°C respectively, for 30 
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A further sample left at room temperature for the same period, that is under 
conditions in which both activities were stable, served as a  standard. At 46°C 
the  antilymphoma  activity was  perfectly stable,  1  ml  of heated  guinea pig 
serum  completely inhibited  5  of  the  6  tumors  implanted;  similarly,  at  this 
temperature T.-asparaginase activity was unaltered. After incubation at 56°C, 
the guinea pig serum was still clearly inhibitory to tumor growth, but there 
was an obvious diminution in its effectiveness, for although the time of tumor 
appearance was delayed from 11 days in untreated controls to 15 to 27 days in 
this group, only 2 out of 6 implanted tumors were completely suppressed. The 
decline in antilymphoma activity was accompanied by a fall in T.-asparaginase 
TABLE III 
The Inavti~a~m of r-Asparaginase in Guinea Pig Serum by Heat 
Sample  No.  Initial ~-as~s. rao 
gin~se activity 
u.~ts*/ml 
55.7 
72.9 
70.2 
62.1 
~-Asparaginase activity (per cent of initial values) after 
incubation for 30 rain. at the following temperatures 
46°C  56°C 
~.5  ~.1 
--  79.3 
--  ~.8 
--  ~.2 
60°C  66°C 
--  15.3 
63.3  17.1 
68.7  12.2 
70.1  14.8 
* Micromoles  of ammonia  liberated in 1 hour, under the standardized conditions  previously 
described. 
assays to 80.1  per cent of the value of unheated samples.  At 66°C  the anti- 
lymphoma activity of guinea pig serum was almost completely destroyed. In 2 
of the 3 treated animals a  slight delay of 2 to 3 days in tumor appearance oc- 
curred, compared with the controls, in the other animal there was no detectable 
inhibition.  This corresponded closely with the destruction of L-asparaginase; 
only 15.3 per cent of enzyme activity remained. 
Within, the limits of the experimental method, then, these results showed a 
close  similarity between  the  heat  stability  of  L-asparaginase  and  the  anti- 
lymphoma agent. This relationship was also found when the stability of these 
two activities to change in pH was examined. 
Inactivation  of  r~-Asparaginase  and  the  Antilymphoma  Substance  of Guinea 
Pig Serum  at Different  ptt  Values.--L-Asparaginase  in guinea pig serum was 
found to be notably unstable to changes in pH, and in a  particular pattern; 
the enzyme was considerably less stable at acid  than at alkaline  values. The 
similar pattern of instability of the antilymphoma substance is shown in Fig. 2. 
At pH 7.0 x-asparaginase was stable, but when incubated for 2 hours at 4.3 
pH units above this value, 37.9 per cent of enzyme activity was lost and the Experimental groups  Result  of implantation * 
Days following implantation 
1. Untreated control 
mice. 
2. Mice given 1.0 ml 
guinea pig serum, 
left at 23°C for 
30 rain. Assay of 
L-asparaginase 
activity: 100% stand- 
ard (55.7 units/ml), 
3. Mice given 1.0 ml 
guinea pig serum, 
left at 46°C for 
30 mln. Assay of 
L-asparaginase 
activity: 99.5%. 
4. Mice given 1.0 ml 
guinea pig serum, 
left  at 56°C for 
30 mln. Assay of 
L-asparaginase 
activity- 80.1%. 
5. Mice given 1.0 ml 
guinea pig serum, 
left at 66°C for 
30 rain. Assay of 
L-asparaginase 
activity: 15.3%. 
Mouse 
No. 
I 
2 
3 
•  •  t  D27 
•  "':'Ill 
•  •  •  t  D23 
•  •  •  t  D24 
O~2cm 
4  N  N  N 
N  N  N 
N  N  N 
5  N  N 
6  N  N 
N  N 
7'  N  N 
N  N 
8  N  N 
N  N 
N  N 
N  N 
JO  N  N  N 
N  N  N 
N  N  N  N  N  N 
N  "  •  •  •  •  t  D26 
N  N  N  N"  N  N  ~-  D34 
N  N  N  "  •  •  • 
N  N  N  N  N  N  N  No  tumor 
N  N  N  N  N  N  N  D60 
N  N  N  "  •  •  • 
N  N  N  N  N  N  N  t  D34 
N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  D 60 
N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  D 60 
N  N  N  N  N  N  Tumor appeared 
N  N  N  N  N  N  D27  t  D43 
N  N  N  N  N  -  •  •  •  2nd tumor appeared 
I  I  N  N  N  N  N  N  N  N  D21  t  D30 
N  N  N  N  !  "  "  "  :  ?D28 
12  N  N  N  N  •  •  • 
13  N  N  •  •  • 
N  N  N  N  •  •  •  14  N  N  -  •  •  •  •  •  •  t  D28 
15  •  •  • 
• 3 ZBC mice in each experimental and control group were implanted with 50,000 6C3HED cells sub- 
cutaneously in each flank. 
FIG.  1. A comparison of the heat stability of L-asparaginase and antilymphoma activities in guinea 
pig serum. 
Portions of a pooled quantity of guinea pig serum were incubated for 30 minutes in water baths at 
23  °, 46  °, 56  °, and 66°C. At the end of this time all were transferred to water at 0°C, and samples were 
immediately taken for assay of ~-asparaginase activity. The sera were injected into experimental animajs 
to measure their antilymphoma activity within 30 minutes of the end of incubation. 
105 Experimental  groups  Result  of implantation 
Mouse 
No. 
1. Untreated control  mice.  ~  I 
2 
3 
2. Mice given  1.0 ml 
guinea pig serum,•  left  4 
at pH 7.00 for 2 hours. 
Assay of L-asparaginase  5 
activity: 100% standard 
(62.9 units/ml).  6 
3. Mice given  1.0 ml  7 
guinea pig serum, left at 
pH 11.23 for 2  hours.  8 
Residual L-asparoglnase 
activity. 62.1%.  9 
4. Mice given  1.0 ml  I 0 
guinea pig serum, left at 
pH 11.96 for 2 hours•  I  I 
Residual L-asparaginase 
activity:  2.3%.  I 
5. Mice given  1.0 ml  I 
guinea pig serum, left at 
pH 5.30 for 2  hours.  I 4 
Residual L-asparaginase 
activity:  69.6%.  1  5 
6. Mice given  1.0 ml  1  6 
guinea pig serum, left at 
pH 4.40 for 2  hours.  1  7 
Residual L-asparaglnase 
activity- 8.3%. 
Days following  implantation 
I0  Ii  12  13  14  15  16  17  18  19  20  21  22 
:  .  ;  gi$ 
"  "  ;  :  I  1111115 °,  
om2.0¢m 
N  N  N  N  N  N  N  N  N  N  N  •  t  D29 
N  N  N  N  N  N  N  N  •  •  •  • 
N  N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  N  N  N  N  N  N  D 60 
N  N  N  N  N  N  -  •  •  •  •  •  • 
N  N  N  N  N  N  N  N  N  N  N  N  t  D31 
N  N  N  N  N  N  N  N  N  -  •  •  • 
N  N  N  N  N  N  N  "  •  •  •  •  •  t  D28 
N  N  N  N  N  N  N  N  N  N  ;  ;  ; 
N  N  N  N  N  e  •  •  •  t  D30 
N  N  N  N  N  N  "  "  •  •  O  O  • 
N  N  N  N  N  N  N  •  •  •  •  08  t  D29 
.  ..  .  .  .  .  .. 
N  N  N  "  •  •  •  t  D26 
N  N  "  •  • 
N"  •  *  .  :  |  |  |  i  8  8  i  tD,6 
N  N  "  •  • 
18 
* Tn 2 further groups of untreated controls, all tumors appeared between the 10th and 13th day, the average 
being the 12th day. 
In a  group of mice given 0.5  ml guinea pig serum, all tumors appeared from the 13th to the 21st day, the 
average being the 16th day. 
FIG. 2. A comparison of the stability at different pH values of L-asparaffinase  and antilymphoma activities in 
guinea pig serum. Method of tumor cell implantation as described in Fig. 1. 
Varying quantities of N HC1 or N NaOH were added from a microburet to 5 ml samples of a pooled quantity 
of g~inea pig serum and these were incubated at 23°C  for 2 hours. At the end of this time the acid added to the 
serum samples was neutralized with an equal quantity of N NaOH or correspondingly the alkali added was neu- 
tralized with ~ HC1. The final volume of each sample was made up to 10 ml by the addition of Ringer's solution. 
After samples were removed for assay of ]~-asparaginase, and within 30 minutes of the end of incubation, the sera 
were injected into experimental animals to measure their antilymphoma activity. 
NNNNNNN !  :i*028 
N  N  N  N  N  N  N  i  •  •  N  N  N  N  N  N  "  "  :  I  tD30 
N  N  N  N  N  N  • 
N  N  N  N  N  N  N  •  • 
N  N  N  N  N  o  •  •  t  D29 
"'"::  "I  I 
•  •  •  •  •  8 
..  ..:::t  N  N  "  •  •  •  8 
.N  •  ..:1  t  I 
N  N  ""  •  •  • 
106 j.  D.  BgOOU~.  107 
serum was notably less effective in inhibiting tumor growth than before. Thus, 
treatment with  1 ml of the preparation of guinea pig serum maintained  at pH 
7.0  completely  suppressed  3  of  6  implanted  tumors.  The  same  quantity  of 
guinea pig serum after incubation at pH 11.3 suppressed only 1 of 6 tumors. At 
pH  11.96  enzyme activity  was  almost  completely destroyed,  and  the  serum 
produced no significant degree  of tumor inhibition.  At acid pH values  a  de- 
crease from neutrality of as little as  1.7 pH units,  to pH 5.3, caused a  loss of 
30.4 per cent  of L-asparaginase  activity,  again  accompanied  by a  significant 
loss of inhibitory  effectiveness  on lymphoma  growth, all  6  implanted  tumors 
grew out and delayed only 6 to 7 days more than the controls. Further acidifica- 
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~.=  80 
O  "O  m~ 
SE 
0  ~ 
o  "  60 
OlD  ~',-  -~.  o  =~  50 
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0 
-  '~  20 
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.E  m  I0 
E" 
O  =.  0 
O 
~5 
0  I0  20  30  40  50  60 
Days of  tumor inhibition 
FIG. 3. The growth inhibition of Lymphoma 6C3HED by preparations  of guinea pig serum 
incubated at different pH values, and its relationship to their x-asparaginase activities. 
The experimental  method  used was that described under Fig. 2. The way in which the 
number of days of tumor inhibition  was derived has been described in the section entitled 
Methods.  •  represents the tumor inhibition produced by 1.0, 0.5, and 0.25 ml quantities  of 
guinea pig serum left at 23°C for 2 hours at pH 7.0. •  represents L-asparaginase activity and 
tumor inhibition produced by 1.0 ml of guinea pig serum after incubation at the following acid 
pH values; 1, pH 5.30; 2, 4.70; 3, 4.40. •  represents similar findings after incubation  at the 
following  alkaline pH values; 4, pH 10.0; 5, 11.23; 6, 11.95. Each point shows the average num- 
ber of days of tumor inh/bition in groups of 3 treated animals. 108  L-ASPARAGINASE  AND  ANTILYMPHOMA  EFFECTS.  I 
tion to pH 4.4 destroyed all but 8.3 per cent of enzyme activity, and the serum 
then had no demonstrable effect on the tumors. The expression of these results, 
together with results from further groups of mice treated with guinea pig serum 
incubated at other pH values, is shown graphically in Fig. 3. Through a  wide 
range of pH variation, antilymphoma activity, measured by "days of tumor 
inhibition" closely paralleled the enzyme assays of the sera. 
These results were confirmed in another experiment performed in a  similar 
way to that shown in Fig. 2, but employing an implantation dose of 500,000 
lymphoma cells on each side. Here, although tumors in the controls appeared 
with a shorter latency than usual, 7 to 8 days, and normal guinea pig serum was 
less effective in inhibiting tumor growth, the same  correspondence was main- 
tained between L-asparaginase activity of guinea pig serum samples incubated 
at different pH values and their effect on the tumor. 
Having thus compared the destruction of antilymphoma and L-asparaginase 
activities by artificial treatment of whole guinea pig serum, a  natural source 
of guinea pig serum was sought in which one or both activities might be reduced. 
Failure of Serum from Newborn Guinea  Pigs to Inhibit Tumor Growth.--The 
serum of the newborn animal of many mammalian species  differs considerably 
in protein composition from that of the adult (10). Now, Ainis eta/. (11) found 
that serum from newborn guinea pigs had no inhibitory activity against the 
Murphy-Sturm sarcoma, a  tumor cell line inhibited strongly by serum from 
adult guinea pigs. On testing lymphoma 6C3HED  a  closely similar result was 
obtained as is shown in Fig. 4. 2 ml of adult guinea pig serum completely sup- 
pressed all tumor growth in 3 treated animals, but 2 ml of neonatal serum failed 
to produce any significant degree of tumor inhibition. Assays of L-asparaginase 
activity of 10 neonatal sera which were pooled to form the material used in the 
test contained from 0 to 5.1 per cent of the enzyme activity of the adult serum. 
The  results  of the  experiments which have been  described  thus far were 
therefore consistent with the supposition that in guinea pig serum, I.-asparagi- 
nase and the antilymphoma substance were identical. Clearly, it was important 
to attempt to characterize L-asparaginase as a protein, to purify it from guinea 
pig  serum,  and  to  determine whether  it  did in  fact possess  antilymphoma 
activity. 
Partial Purification of L-Asparaginase  from Guinea Pig Serum.--The experi- 
ments to be described form a succession of steps by which L-asparaginase was 
separated in increasing degree from other proteins in guinea pig serum. 
At each of these steps all the fractions separated were tested for antilym- 
phoma activity, to determine not only whether those containing L-asparaginase 
produced tumor inhibition, but also to determine whether any other protein 
fraction could produce the same effect. 
1.  Precipitation  of L-Asparaginase  by high salt concentration: L-Asparaginase 
was  first  concentrated  from  guinea pig  serum  by precipitation  with  other j.  I).  Bgoo~s  109 
Experimental groups 
Mouse 
No. 
1. Untreated control mice.  I 
2. Mice given 2.0 ml 
pooled serum from 
adult guinea pigs. 
L-asparaginase activity: 
100.0%. Standard 
(60.7 units/ml). 
3. Mice given 2.0 ml 
pooled serum from 
newborn guinea pigs. 
L-asparaginase activity: 
0.7%. 
I! 
N 
O 
N 
2 
N 
3 
N 
N 
4 
N 
N 
5 
N 
N 
6 
N 
7 
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@ 
N 
9 
N 
Result of implantation 
Days following implantation 
12  13  14  15  16 
o  Q  •  •  • 
t  D29 
•  •  •  •  • 
•  •  •  l)  O  t  D2s 
°  *  *  •  O  •  •  •  •  O  tD28 
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N  N  N  N  N  No tumor 
N  N  N  N  N  D60 
N  N  N  N  N  No tumor 
D 60 
N  N  N  N  N 
N  N  N  N  N  No tumor 
D 60 
N  N  N  N  N 
•  •  •  •  • 
•  •  •  •  • 
"l'  D24 
•  •  •  •  • 
•  •  •  •  0  tD25 
N  c;  •  •  • 
r~  *  •  •  • 
t  D28 
FIo. 4. The failure of serum from newborn guinea pigs to inhibit the growth of Lymphoma 6C3HED. Method 
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proteins insoluble in 15 gm per cent sodium sulfate, as in the experiment shown 
in Fig. 5. Precipitate and supernatant were separately dialyzed against buffered 
1.0 gm per cent sodium chloride, following which solutions of each were made 
up in a volume equal to that of the whole guinea pig serum from which they 
were derived. 68.5 per cent of the recovered L-asparaginase activity was in the 
precipitated fraction, which contained only 25.5 per cent of the total recovered 
protein. When the antilymphoma activities of the supernatant and precipitate 
were assayed they were found to correlate very closely with measurements of 
the L-asparaginase activities. Thus, in the experiment shown in Fig. 5, 2 ml of 
the  sodium sulfate precipitated  fraction with  103.9  units  of L-asparaginase 
activity caused complete suppression of tumor growth in all 3 treated animals; 
1 ml of solution from this fraction completely suppressed  4  of 6  implanted 
tumors. Whole guinea pig serum possessing similar amounts of enzyme activity, 
produced similar inhibitory effects, 1 ml with 81.0 units suppressed 5 of 6 im- 
planted tumors and 0.5 ml suppressed 4 of 6. The supernatant produced con- 
siderably less powerful inhibition but again closely corresponding to the assay 
of its enzyme activity. 
2.  Electrophoresis:  In a  previous publication (13),  it was shown that when 
guinea pig serum was electrophoresed on a starch block in 0.1 M veronal buffer 
at pH 8.5  by the method of Kunkel and Slater  (14),  L-asparaginase activity 
formed a  single peak in the ~2-globulin fractions. It was also shown, and has 
been  confirmed using different buffer systems, that inhibition  of lymphoma 
growth was produced  only by fractions from the  electrophoretic separation 
which contained L-asparaginase activity and that the degree of inhibition was 
directly related to this. 
To obtain a  more highly purified enzyme preparation from electrophoresis 
than was possible using whole guinea pig serum, a fraction twice precipitated 
from  15  gm per  cent  sodium sulfate,  as  described  previously,  was  used  as 
starting material. It will be seen in Fig.  6  that this consisted mostly of ~,- 
globulin, migrating to the cathode, in a direction opposite to that of L-asparagi- 
nase.  The  enzyme appeared  as a  single peak, and moving faster than most 
other components, in a  region of relatively low protein concentration. In the 
most active L-asparaginase-containing fraction (No. 32)  the ratio of enzyme 
activity to protein concentration was increased by a factor of 88 in comparison 
with that  of the original serum.  Nevertheless,  considerable  enzyme activity 
was lost in the purification process, from the activity possessed by the 100 ml 
of whole guinea pig serum which formed the starting material, only 23 per cent 
was recovered from the starch block. 
When each of the eluted fractions from the starch block was tested in vivo 
only the fractions containing L-asparaginase produced a  detectable degree of 
tumor inhibition.  The  quantitative relationship between L-asparaginase and 
antilymphoma activities of the protein fractions is clearly shown in Fig. 7. The Experimental groups  Result of implantation 
1. Untreated control mice.  ~ 
Mouse 
No. 
I 
2 
3 
2. Given 1.0 ml guinea pig  ~" 
serum,*  L-asparaginase 
activity:  81.0 units/ml.  5 
6 
3, Given 0.5 ml guinea pig  7 
serum.§ 
8 
9 
4. Given 2.0 ml fraction  1  I  0 
(precipitate).  (L-asparaginase 
activity:  63.4% of that in  |  | 
whole guinea pig serum.) 
12 
5. Given 1.0 ml fraction  1. 
6. Given 2.0 ml fraction  2 
(supernotant). 
(,-asparaginase activity: 
29.2% of that in whole 
guinea pig serum.) 
7. Given 1.0 ml fraction  2. 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Days following implantation 
I0  II  12  13  14  15  16  17  18  19  20  21  22  23 
o  ,:.  •  •  •  •  •  •  •  •  •  •  •  • 
N  •  •  •  •  •  •  •  •  •  •  •  •  •  tD27 
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N  N  N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  D  60 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  D  60 
N  N  N  N  N  N  N  N  N  N  N  •  •  •  t  D43 
N  N  N  N  N  N  N  N  N  N  N  N  N  N 
N  N  N  N  N  N  N  N  N  N  N  N  N  N 
N  N  N  N  N  N  N  N  N  N  N  N  --  •  1"  D33 
N  N  N  N  N  N  N  •  •  •  •  •  •  • 
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N  N  N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
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N  N  N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  D 60 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  D  60 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  D 60 
N  N  N  N  N  N  N  N  N  N  N  N  N  N 
N  N  N  N  N  N  N  N  N  N  •  •  •  •  t  D34 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  D 60 
N  N  N  N  N  N  N  N  N  N  N  N  N  N 
N  N  N  N  N  N  N  •  t  •  •  •  •  •  t  D36 
N  N  N  N  N  N  N  "  •  •  •  •  •  • 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  t  D32 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  t  D34 
N  N  N  N  N  N  N  '  •  •  •  •  •  • 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  "]"  D42 
N  N  N  N  N  N  N  N  N  N  N  N  N  • 
N  N  N  N  '"  •  •  •  •  •  •  •  •  •  tD33 
N  N  N  N  •  •  •  •  •  •  •  •  •  • 
N  N  N  N  N  N  N  N  N  •  •  •  •  O- 
N  N  N  N  •  •  •  •  •  •  •  •  •  •  1"  D34 
N  N  N  •  •  •  •  •  •  •  •  •  •  • 
N  N  N  .  •  •  •  •  •  •  •  •  •  •  tD31 
* In 4 additional groups of untreated controls tumors appeared on the 9th to llth day. 
~: ~  a  further group of animals given 1 ml of guinea p~ serum all tumors were suppressed. 
§  n  a  further group of antma]s given 0.5 ml of guinea pig serum, 2 mice developed tcmors on the 17th to 24th day. 
Ly Fxc. 5. Thee ff~t of preparations of ]~-asparaginase obtained by sodium sulfate precipitation of guinea pig serum on the growth of 
mpnoma 6L~l:i~u in rive. 
..L-Aspara~inase was precipitated from guinea pig serum by the addition of an equal volume of 30 gin per cent  sodium sulfate as de- 
SCrlOea oy ~elster 02), reaving the mixture at 20--25°C for 2 hours. After separation from the supernatant  the ~recipitate was dissolved 
in distilled water and reprecipitated as before. Protein preparations were dialyzed for a period of 24 hours  at 4  C against 0.15 x  sodium 
cheered• with 0.01 ~  phosphate buffer at pH 7.0,  before assay for enzyme activity and before injection into experimental animals. 
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eluate with the maximum L-asparaginase activity (No. 32, 56.7 units per ml) 
caused complete tumor suppression in all treated  animals. Eluates on either 
side of this were proportionately less effective. 
40~ 
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FIG. 6. Purification by electrophoresis of L-asparaginase from other guinea pig serum pro- 
teins insoluble in 15 gm per cent sodium sulfate. 
100 ml of pooled guinea pig serum was mixed with an equal volume of 30 gm per cent 
NaSO4 and allowed to stand at 20  ° to 25°C for 1 hour. The precipitate  was recovered by 
centrifuging, dissolved in 100 ml of distilled water, and reprecipitated.  After dissolving this 
second precipitate in distilled water it was dialyzed against 0.1 xr veronal buffer at pH 8.4 and 
concentrated to a volume of 20 ml in collodion bags (obtained from the Schieicher and Schiill 
Company, Keene, New Hampshire) to the outside of which suction was applied. The dialyzed 
protein was electrophoresed by the technique of Kunkel and Slater (16), in a block of potato 
starch  45 cm in length, 35 cm in breadth,  and 1.3 cm depth formed from a slurry in the 
veronal buffer described. A current of 700 v at approximately 100 ma for 40 hours was used, 
and the block kept at 2°C. After electrophoresis the block was cut into 1 cm strips from each 
of which protein was eluted using 7 ml of 0.15 M NaC1. Eluates were dialyzed against 0.15 xr 
NaC1 and 0.01 M  phosphate buffer at pH 7.3, to remove veronal, following  which samples were 
removed to measure protein  concentration  and L-asparaginase activity. The eluates  were 
then injected without delay into test animals to assay their tumor inhibitory activity. 
From the "chartings" of this and other experiments in which L-asparaginase 
was purified by electrophoresis, however, it is obvious that such enzyme prepara- 
tions were consistently less effective in inhibiting tumor growth in relation to 
their L-asparaginase assays than was whole guinea pig serum. In the present 
experiment, each of 12 mice, placed in 4  separate groups of 3 at intervals be- 
tween the rest were  treated  with  1 ml of whole guinea pig serum containing Experimental  groups  Result of implantation 
Mouse 
1. Untreated controls. ~  N/.o 
2 
3 
2. Mice given 2.0 ml  12 3 
eluate No. 29 
L-asparaginase  12 4 
6.2 units.  J 2  5 
3. Mice given 2.0 ml  12 6 
eluate No. 30 
L-asparaginase  12 7 
38.6 units.  12 8 
4. Mice given 2.0 ml 
eluate No. 31 
L-asparaginase 
85.5 units. 
5. Mice given 2.0 ml 
eluate No. 32 
L-asparaginase 
113.4 units. 
Days following implantation 
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N  N 
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N  N 
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6. Mice given 2.0 ml  13 5 
eluate No. 33 
L-asparaginase  136 
66.1  units.  137 
7. Mice given 2.0 ml  138 
eluate No, 34 
L-asparaginase  J 3  9 
35.6 units.  140 
8. Mice given 2.0 ml  14 I 
eluate No. 35 
L-asparaginase  1~2 
1.5 units.  |43 
N  N  N  N  N  N  N  N  N  •  •  "  t  D34 
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N  N  N  N  N  N  N  N  N  N  N  N  D  60 
N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  N  N  N  N  N  D  60 
N  N  N  N  N  N  N  N  N  N  N  N  No tumor 
N  N  N  N  N  N  N  N  N  N  N  N  D  60 
"  "  "  "  "  "  "  i  i  i  :  :  :  .  .  .  .  .  .  N  N  N  N  N  N  N  N  N  N  N 
N  N  N  N  N  N  •  •  •  •  •  •  •  •  t  D35 
N  N  N  N  N  N  N  N  N  N  N  N  N  N  t  D36 
N  N  N  N  N  N  N  •  •  •  •  •  •  • 
N  N  N  •  •  •  •  •  •  •  •  •  =  t 
N  N  N  •  •  •  •  •  •  •  •  •  --  t  D27 
N  N  N  •  •  •  •  •  •  •  •  :  1 
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N  N  N  N  N  *  •  •  •  •  "  "  :  t  D28 
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• For the growth pattern of tumors in other controls and in animals treated with varying quantities of whole 
pig serum, see Experiment 1 of Tables I and II. 
~:~umors were not examined on the days left blank. 
FIG. 7. Inhibition of the growth of 6C3HED tumors by  electrophoretically separated  fractions of guinea pig 
which possessed L-asparaginase  activity. Method of lymphoma cell implantation and treatment of implanted 
amim~ was that shown in Fig. 1. 
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69.2 L-asparaginase units. No tumor appeared in any of these treated animals. 
Now, the only fraction from electrophoresis which produced complete suppres- 
sion of tumor growth in a group of 3 animals contained 113.4 units, 64 per cent 
more enzyme activity than in 1 ml of whole guinea pig serum. A similarly de- 
creased effectiveness of purified L-asparaginase preparations in inhibiting tumor 
growth, in relation to their enzyme activity, was found in extracts  containing 
smaller amounts of the enzyme. 
A further experiment performed in a similar way but using for electrophor- 
esis veronal buffer at pH 8.6, provided results which confirmed all the signifi- 
cant findings in the previous experiment. 2 ml injections of the eluate  having 
maximum L-asparaginase activity (65.7 units/ml) suppressed 5 of 6 implanted 
tumors. But 1 ml of whole guinea pig serum,  containing 82.9  units/ml, sup- 
pressed 16 of 18 implanted tumors in 9 animals. The degree of tumor inhibition 
brought about in these 2 cases may he considered to be approximately equal. 
It was necessary therefore to treat mice with purified preparations containing 
59 per cent more L-asparaginase activity than was present in amounts of whole 
guinea pig serum which brought about a similar result. The possible significance 
of this finding will be discussed later. 
3.  Chromatography on DEAE cellulose: To bring about further purification of 
L-asparaginase a  three stage process was used. In  this,  enzyme was precipi- 
tated from guinea pig serum with proteins insoluble in  15 gm per cent sodium 
sulfate; as in the previous section these were subjected to electrophoresis on the 
starch  block,  and  eluates  containing  the  maximum  L-asparaginase  activity 
were now pooled and absorbed on a  column of I)EAE cellulose. Enzyme was 
eluted from the column by the  schedule shown in the  Fig. 8.  Of numerous 
elufion schedules  which  were  tried,  this  was  the  most  satisfactory for  the 
specific requirements of the experiment, namely to produce the highest degree 
of  purification  consistent  with  obtaining  the  eluted  materials  in  sufficient 
concentration to allow testing for their antilymphoma activity. 
-, In the present experiment the total yield of L-asparaginase activity in the 
eluates represented only 12 per cent of that in the 200 ml guinea pig serum 
used  as  starting  material.  This  result  was  somewhat disappointing  for  the 
maximum ratio of L-asparaginase activity to protein concentration was thus 
raised very little compared with that of the material obtained simply by elec- 
trophoresis; it now reached a factor of 118 compared with the original whole 
guinea pig serum. Attempts to further purify L-asparaginase were unsuccessful 
owing  to  the  considerable  instability  of  the  partially  purified  enzyme.  L- 
asparagine, glutathione, L-cysteine, or versene when added to enzyme solutions 
brought about no notable stabilizing effect. 
L-Asparaginase appeared in 2 peaks, which in 2 other experiments have been 
separated considerably more widely. Most of the enzyme was eluted before the 
peak in protein concentration. ~. D. BROO~E  115 
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Eluates were tested for their antilymphoma activity as before, but here to 
obtain an effective assay it was necessary to give each animal 2 injections of 2 
ml at intervals 6 hours apart. Such is the extraordinary resilience of mice that 
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* Animals healthy and without evidence of tumor growth 49 days after implantation. 
FIG. 9. The antilymphoma activity of L-asparaginase fractions separated by chromatog- 
raphy on DEAE ceUulose. 
3 ZBC mice in each experimental group were implanted with cells of Lymphoma 6C3HED 
in the standard way described in previous experiments. For the outcome of implantations in 
the groups which served as untreated control mice and in those given 0.25 to 2.0 ml quantities 
of whole guinea pig serum immediately following implantation, see Experiment 3  of Tables I 
and II. 
In the present experiment, to assay tumor inhibitory activity of the eluates from  the 
chromatographic column, 2 injections each of 2 ml of eluates were given intraperitoneally  with 
an interval of 6 hours between injections, as described in the text. 
these large volumes of fluid produced no apparently harmful effects; treated 
mice  remained  sleek  and  active  and  18  hours  later  their  weights  were  not 
significantly different from  those  before  the  experiment.  No  change  in  the 
effectiveness of the graded quantities of guinea pig serum used as a  standard 
for  tumor  inhibitory  activity  was  observed  when  these  were  administered, 
diluted in Ringer's solution in the same volume as the eluates. J.  D.  BROOME  117 
The results of measurements of antilymphoma activity are shown in Fig. 9. 
As  in  previous  experiments,  only  those  fractions  possessing  T.-asparaginase 
activity produced tumor inhibition,  but, in contrast to the previous findings 
in which a single peak of enzyme activity occurred and in which tumor inhibi- 
tion was proportional to the enzyme assays, here tumor inhibition was notably 
more powerful in fractions from the first enzyme peak than from the second. 
A definite degree of tumor inhibition was produced by fractions 61 and 62 
which provided 19.3 u. of T.-asparaginase activity to each mouse, and tumor 
inhibition  increased proportionately with enzyme assays to the height of the 
first peak; fractions  68  and  69,  providing  101.9 units,  produced 63  days of 
tumor inhibition, measured in the way already described, and "cured" 1 out of 
3 mice.  Similarly fractions 70 and  71, providing 93.6 L-asparaginase  units to 
each mouse (and just past the enzyme peak), produced 65 days of tumor inhibi- 
tion and cured 1 of 3 mice. With later eluates, although enzyme activity rose 
again in a second peak, there was a steady decline in the lymphoma inhibition 
they produced and even at the height of the second peak, fractions 74 and 75, 
providing 105.5 units of enzyme per mouse and more than any other fraction, 
produced only 42 days of tumor inhibition  and cured none of the implanted 
animals.  The difference between tumor inhibitory activity and enzyme activity 
became more marked with the decline  from the second peak. These findings 
are subject to a number of possible interpretations which will be discussed later. 
DISCUSSION 
The observations of others that guinea pig serum is unique amongst numerous 
animal  sera in producing inhibition  of the growth of certain  lymphomas {n 
~vo (1, 2) and also in containing L-asparaginase  (6) led to the experiments here 
descrlbed3 The results provide substantial  indication  that  this  enzyme is re- 
sponsible  for  lymphoma  inhibition.  Within  the  limits  of  the  experimental 
methods used, the stability of the antilymphoma  substance at different tem- 
peratures is indistinguishable from that of L-asparaginase;  so too, the stability 
at different pH values. Furthermore, guinea pig serum from newborn animals, 
which possessed no L-asparaginase  activity, produced no inhibition  of tumor 
growth. In purification of L-asparaginase  both by salt precipitation and electro- 
phoresis the degree of tumor inhibition  brought about by different fractions 
was directly related to their enzyme activity. 
The fact that antilymphoma activity of L-asparaginase  preparations purified 
in 2 stages by salt precipitation and electrophoresis was persistently about 
Old, L. J., Boyse, E. A., Campbell, H. A., and Daria, G. M.,  (Nature,  1953, in press) 
have recently found that animals of 4 further species of the supeffamily Cavioidea, to which 
the guinea pig belongs, have n-asparaginase  activity in their sera,  in this respect differing 
from animals of other rodent families. Furthermore, in all sera tested a close correlation was 
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less  than  that  produced  by amounts  of  whole guinea pig  serum  of similar 
enzyme assay requires some consideration. A number of experiments showed 
this was not due to the greater volumes or lower total protein concentrations of 
the purified enzyme preparations.  Other unreported experiments showed that 
it was  not due  to  impurities introduced from the  starch  block or dialyzing 
apparatus  which  might have  had  an  effect preventing  tumor  inhibition.  It 
remains possible that L-asparaginase was split during purification from a  co- 
factor enhancing its antilymphoma activity, or more particularly, responsible 
for maintaining its stability. The instability of L-asparaginase is very marked 
when it is purified to any extent, as has been abundantly shown in the present 
experiments, and it is therefore quite likely that inactivation of purified enzyme 
would continue in treated animals at a faster rate than when the enzyme was 
given in whole guinea pig serum. 
The  2  peaks  of L-asparaginase activity found in  the  present  experiments 
after  separating  guinea  pig  serum  proteins  by  chromatography  on  DEAE 
cellulose,  and by Wriston (15)  in other experiments using whole serum, may 
indicate the existence of 2 L-asparaginase isozymes. But this is not necessarily 
so; it is possible, particularly in view of the instability of the enzyme, that one 
or both forms were produced as artefacts during the purification procedure; 
such changes have been observed with a number of other purified proteins (see, 
for  instance,  Lindskog, reference  16,  and  Kaplan and  Grumbach,  reference 
17). 
The difference in the present experiments, between the antilymphoma ac- 
tivities of materials from the 2 peaks may have various causes. Thus, the 2 
forms  of L-asparaginase may have inherently different capacities  for  tumor 
inhibition. But alternatively the present observations may be due to a difference 
in stability in vitro of the 2 enzyme forms. The effect of such a difference would 
be accentuated by the experimental technique used, for all protein fractions 
were given to treated mice in 2 injections 6 hours apart. 
That  enzymes  might  have  considerable  potentiality as  tumor  inhibitory 
agents was recognized by Bergel and discussed by him in a recent monograph 
(18).  Earlier, Haddow, Bergel, and their associates treated mice bearing spon- 
taneous mammary tumors with xanthine oxidase, and produced a measurable 
inhibition of tumor growth (19, 20). Ledoux subsequently showed that prepara- 
tions of ribonuclease when injected intraperitoneally brought about inhibition 
of a number of different lines of mouse ascites tumors (21). More significantly, 
detectable inhibition was also produced in the growth of solid tumors of several 
cell lines  (22).  de Lamirande found that desoxyribonuclease could produce in 
vivo some degree of inhibition of the growth of the Ehrlich ascites tumor (23). 
In the experiments mentioned it was necessary, however, to treat animals with 
large  quantities  of crystalline enzyme to  produce  any detectable  degree  of 
tumor inhibition.  If L-asparaginase is  in  fact the  tumor inhibitory agent of 
guinea pig serum, then its inhibitory activity on tumor cells of sensitive lines is J.  D.  BROOMF.  119 
very much more powerful than  that produced by the other enzymes tested 
thus  far.  The  considerable potency of L-asparaginase may be  related  to  its 
ability to act on a  specific abnormality in the metabolism of sensitive tumor 
cells. This will be considered in the succeeding paper. 
S~LRY 
A number of the properties of the L-asparaginase present in guinea pig serum 
have been examined and shown to be indistinguishable from those of the agent 
responsible for inhibiting cells of lymphoma 6C3HED in vivo. 
The patterns of instability of the enzyme to changes in temperature and pH 
were found to parallel closely those of the antilymphoma agent. L-Asparaginase 
activity was  essentially absent from the  serum of newborn guinea pigs and 
this failed to inhibit 6C3HED  cells.  On separating guinea pig serum proteins 
by salt precipitation, electrophoresis, and chromatography on DEAE cellulose, 
antilymphoma activity was found only in fractions which contained L-aspara- 
ginase. 
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